Avadel Pharmaceuticals plc (AVDL)

USD 10.33

(-3.73%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 261.12 Million 132.78 Million 247.26 Million 311.63 Million 151.43 Million 190.3 Million
Total Current Assets 134.2 Million 100.84 Million 192.49 Million 263.45 Million 82.38 Million 124.85 Million
Cash And Short Term Investments 105.11 Million 96.49 Million 157.22 Million 221.4 Million 64.15 Million 99.91 Million
Cash and Cash Equivalents 31.16 Million 73.98 Million 50.7 Million 71.72 Million 9.77 Million 9.32 Million
Short Term Investments 73.94 Million 22.51 Million 106.51 Million 149.68 Million 54.38 Million 90.59 Million
Net Receivables 13.42 Million 2.24 Million 2.44 Million 3.32 Million 10.38 Million 13.91 Million
Inventory 10.38 Million - - - 3.57 Million 4.77 Million
Other Current Assets 5.28 Million 2.09 Million 32.82 Million 38.72 Million 4.26 Million 759 Thousand
Total Non-Current Assets 126.92 Million 31.94 Million 54.77 Million 48.18 Million 69.05 Million 65.44 Million
Net PPE 3.17 Million 2.55 Million 2.93 Million 2.96 Million 4.15 Million 7.8 Million
Good Will And Intangible Assets 16.83 Million 16.83 Million 16.83 Million 16.83 Million 19.3 Million 20.12 Million
Good Will 16.83 Million 16.83 Million 16.83 Million 16.83 Million 18.49 Million 18.49 Million
Intangible Assets - - - - 813 Thousand 1.62 Million
Long-Term Investments 332 Thousand 1.23 Million -22.9 Million -14.81 Million -23.1 Million 8.74 Million
Tax Assets 96.42 Million 71.34 Million 24.12 Million 18.25 Million 29.42 Million 23.02 Million
Other Non Current Assets 10.15 Million -60.01 Million 33.77 Million 24.93 Million 39.27 Million 5.74 Million
Other Assets - - - - - -
Total Liabilities 173.38 Million 153.93 Million 169.02 Million 149.37 Million 180.63 Million 187.52 Million
Total Current Liabilities 36.85 Million 55.79 Million 21 Million 15.1 Million 35.98 Million 38.38 Million
Account Payables 11.43 Million 7.89 Million 7.67 Million 2.93 Million 6.1 Million 3.5 Million
Tax Payables - - - - - 73 Thousand
Short Term Debt 934 Thousand 38.62 Million 900 Thousand 474 Thousand 645 Thousand 106 Thousand
Deferred Revenue - - 7.15 Million 6.5 Million 25.36 Million 114 Thousand
Other Current Liabilities 24.48 Million 9.27 Million 5.27 Million 5.2 Million 3.87 Million 34.66 Million
Total Non Current Liabilities 136.53 Million 98.13 Million 148.02 Million 134.26 Million 144.65 Million 149.13 Million
Long-Term Debt 32.75 Million 92.39 Million 144.1 Million 130.05 Million 124 Million 115.73 Million
Deferred Revenue Non Current 1.69 Million -71.34 Million - - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.65 Million 5.74 Million 3.91 Million 4.21 Million 20.64 Million 33.4 Million
Other Liabilities - - - - - -
Total Equity 87.73 Million -21.14 Million 78.24 Million 162.26 Million -29.19 Million 2.78 Million
Stock Holders Equity 87.73 Million -21.14 Million 78.24 Million 162.26 Million -29.19 Million 2.78 Million
Common Stock 898 Thousand 628 Thousand 586 Thousand 583 Thousand 429 Thousand 427 Thousand
Retained Earnings -745.49 Million -585.22 Million -447.75 Million -384.18 Million -391.21 Million -357.98 Million
Accumulated other comprehensive income -23.16 Million -26.34 Million -23.94 Million -21.05 Million -22.8 Million -23.41 Million
Common Stock Equity 87.73 Million -21.14 Million 78.24 Million 162.26 Million -29.19 Million 2.78 Million
Capital Lease Obligation 1.69 Million 1.74 Million 2.6 Million 2.31 Million 2.96 Million -
Total Investments 74.27 Million 22.51 Million 106.51 Million 149.68 Million 54.38 Million 90.59 Million
Total Debt 35.38 Million 131.02 Million 145 Million 130.52 Million 124.65 Million 115.84 Million
Net Debt 4.21 Million 57.04 Million 94.29 Million 58.8 Million 114.87 Million 106.51 Million

Balance Sheet Charts